Chemically controlling chromatin to treat friedriech's ataxia

Ended Project Grant Awarded Last action

Award ID
R41TR003245
Recipient
Awarding agency
Obligated
$251,236

Award facts

Assistance listing
93.350 National Center for Advancing Translational Sciences
Completion date
Originally
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Chemically controlling chromatin to treat friedriech's ataxia - we recently developed a technology that combines catalytically inactive DCAS9 with… $0
Original award $251,236

Quick answers

Who received award R41TR003245?

R41TR003245 was awarded to Epigenos Bioscience Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on April 1, 2020.

How much is award R41TR003245 worth?

$251,236 has been obligated on R41TR003245.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award